跳至主要内容
临床试验/NCT05392725
NCT05392725尚未招募不适用

Epidemiological Study on Malignancy Complicated With Renal Injury

RenJi Hospital0 个研究点目标入组 30,000 人开始时间: 2022年12月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30,000
主要终点
survival

研究概览

简要总结

The epidemiological study of tumor complicated with kidney disease can clarify the prevalence and risk factors of renal injury when malignant tumor is diagnosed, and understand the impact of malignant tumor complicated with renal injury on survival time. This study will bring enlightenment to clinicians, discover high-risk factors in time, and try to avoid renal damage factors in diagnosis and treatment. Early diagnosis and early treatment can partially terminate the progress of renal injury, avoid the suspension of treatment due to renal reasons, and avoid the occurrence of end-stage renal failure (ESRD).

详细描述

  1. To determine the prevalence of malignant tumor complicated with renal injury and analyze the related risk factors.
  2. To compare the survival time of malignant tumor with or without renal injury

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Malignancy confirmed by pathology.
  • Between 18-80 years old, regardless of gender; Patients initially diagnosed with malignant tumors in our hospital from July 2017 to June 2021; Waiver of informed consent.

排除标准

  • Patients with benign tumor diagnosed by pathology; The patient refused to participate; Patients judged by other researchers as unsuitable for inclusion in the study.

结局指标

主要结局

survival

时间窗: 3 years

survival time

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lulin Min

Attending

RenJi Hospital

相似试验